In the current cohort, PD-L1+ve/high tumor cells were 24 (18%) cases, while combined PD-L1+ve/high tumor cells and TAIs were 33 (24%) cases, out of the studied HNSCC (Table 2). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.